Monday, December 11, 2017
 
 
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access
Strategic Collaboration Aimed at Exclusive Test Development and Commercialization of Proprietary Genomic Health Tests on the Idylla™ Platform
(September 13, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Disease,healthcare,Cancer,Surgery,Womens Health,Science,Medical,Genetics,Cancer,Business,Other,
Related Sites: AEC Newsroom ,   DMN Newswire ,   itbusinessnet.com ,   IBN - SoftwareDev ,   HTN - Health Technology Net
Related Newsletter: DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines